Identification Of Clinical Characteristics Of Patients Whose Tumor Cells May Respond To Gmcsf Priming Prior To Monoclonal Antibody Therapy. P Venugopal, A Subramoniam,S Sivaraman, S Narula, S Baseer,T O'Brien,K O'Donnell, A Jajeh,Sa Gregory,Hd PreislerBLOOD（2000）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
